228 related articles for article (PubMed ID: 34931062)
1. Characterization of a patient-derived variant of GPX4 for precision therapy.
Liu H; Forouhar F; Seibt T; Saneto R; Wigby K; Friedman J; Xia X; Shchepinov MS; Ramesh SK; Conrad M; Stockwell BR
Nat Chem Biol; 2022 Jan; 18(1):91-100. PubMed ID: 34931062
[TBL] [Abstract][Full Text] [Related]
2. Cardiolipin drives the catalytic activity of GPX4 on membranes: Insights from the R152H mutant.
Roveri A; Di Giacinto F; Rossetto M; Cozza G; Cheng Q; Miotto G; Zennaro L; Di Paolo ML; Arnér ESJ; De Spirito M; Maiorino M; Ursini F
Redox Biol; 2023 Aug; 64():102806. PubMed ID: 37413766
[TBL] [Abstract][Full Text] [Related]
3. Sedaghatian-type spondylometaphyseal dysplasia: Whole exome sequencing in neonatal dry blood spots enabled identification of a novel variant in GPX4.
Fedida A; Ben Harouch S; Kalfon L; Abunassar Z; Omari H; Mandel H; Falik-Zaccai TC
Eur J Med Genet; 2020 Nov; 63(11):104020. PubMed ID: 32827718
[TBL] [Abstract][Full Text] [Related]
4. GPX4 in cell death, autophagy, and disease.
Xie Y; Kang R; Klionsky DJ; Tang D
Autophagy; 2023 Oct; 19(10):2621-2638. PubMed ID: 37272058
[TBL] [Abstract][Full Text] [Related]
5. MiR-15a-3p regulates ferroptosis via targeting glutathione peroxidase GPX4 in colorectal cancer.
Liu L; Yao H; Zhou X; Chen J; Chen G; Shi X; Wu G; Zhou G; He S
Mol Carcinog; 2022 Mar; 61(3):301-310. PubMed ID: 34727409
[TBL] [Abstract][Full Text] [Related]
6. Characterization of phospholipid hydroperoxide glutathione metabolizing peroxidase (gpx4) isoforms in Coho salmon olfactory and liver tissues and their modulation by cadmium.
Wang L; Harris SM; Espinoza HM; McClain V; Gallagher EP
Aquat Toxicol; 2012 Jun; 114-115():134-41. PubMed ID: 22446825
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.
Zhang X; Sui S; Wang L; Li H; Zhang L; Xu S; Zheng X
J Cell Physiol; 2020 Apr; 235(4):3425-3437. PubMed ID: 31556117
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the enzyme glutathione peroxidase 4 cause Sedaghatian-type spondylometaphyseal dysplasia.
Smith AC; Mears AJ; Bunker R; Ahmed A; MacKenzie M; Schwartzentruber JA; Beaulieu CL; Ferretti E; ; Majewski J; Bulman DE; Celik FC; Boycott KM; Graham GE
J Med Genet; 2014 Jul; 51(7):470-4. PubMed ID: 24706940
[TBL] [Abstract][Full Text] [Related]
9. The central role of glutathione peroxidase 4 in the regulation of ferroptosis and its implications for pro-inflammatory cytokine-mediated beta-cell death.
Krümmel B; Plötz T; Jörns A; Lenzen S; Mehmeti I
Biochim Biophys Acta Mol Basis Dis; 2021 Jun; 1867(6):166114. PubMed ID: 33662571
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis.
Hu CL; Nydes M; Shanley KL; Morales Pantoja IE; Howard TA; Bizzozero OA
J Neurochem; 2019 Feb; 148(3):426-439. PubMed ID: 30289974
[TBL] [Abstract][Full Text] [Related]
11. Characterization and structural analysis of human selenium-dependent glutathione peroxidase 4 mutant expressed in Escherichia coli.
Yu Y; Song J; Guo X; Wang S; Yang X; Chen L; Wei J
Free Radic Biol Med; 2014 Jun; 71():332-338. PubMed ID: 24681209
[TBL] [Abstract][Full Text] [Related]
12. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.
Sha R; Xu Y; Yuan C; Sheng X; Wu Z; Peng J; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
EBioMedicine; 2021 Sep; 71():103560. PubMed ID: 34482070
[TBL] [Abstract][Full Text] [Related]
13. NFE2L1-mediated proteasome function protects from ferroptosis.
Kotschi S; Jung A; Willemsen N; Ofoghi A; Proneth B; Conrad M; Bartelt A
Mol Metab; 2022 Mar; 57():101436. PubMed ID: 34999280
[TBL] [Abstract][Full Text] [Related]
14.
Furuita K; Inomata K; Sugiki T; Kobayashi N; Fujiwara T; Kojima C
Biomol NMR Assign; 2022 Oct; 16(2):267-271. PubMed ID: 35616778
[TBL] [Abstract][Full Text] [Related]
15. GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis.
Forcina GC; Dixon SJ
Proteomics; 2019 Sep; 19(18):e1800311. PubMed ID: 30888116
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent Turn-On Probes for Visualizing GPx4 Levels in Live Cells and Predicting Drug Sensitivity.
Wang S; Yu H; Li L; Zhang M; Fu Y; Lin Z; Li J; Zhong F; Liu H; Wu Y
Anal Chem; 2023 Jun; 95(23):8939-8947. PubMed ID: 37256969
[TBL] [Abstract][Full Text] [Related]
17. Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5/GPX4 axis.
Li H; Liu W; Zhang X; Wu F; Sun D; Wang Z
Biochem Biophys Res Commun; 2021 Dec; 585():111-116. PubMed ID: 34800882
[TBL] [Abstract][Full Text] [Related]
18. Metformin induces ferroptosis by targeting miR-324-3p/GPX4 axis in breast cancer.
Hou Y; Cai S; Yu S; Lin H
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):333-341. PubMed ID: 33522578
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3ε.
Vučković AM; Bosello Travain V; Bordin L; Cozza G; Miotto G; Rossetto M; Toppo S; Venerando R; Zaccarin M; Maiorino M; Ursini F; Roveri A
FEBS Lett; 2020 Feb; 594(4):611-624. PubMed ID: 31581313
[TBL] [Abstract][Full Text] [Related]
20. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy.
Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
